Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cipla
Fuji
Citi
AstraZeneca
Farmers Insurance

Generated: July 20, 2019

DrugPatentWatch Database Preview

Litigation Details for Engate Inc v. Esquire Deposition (N.D. Ill. 2001)

Try a free trialSee Plans and Pricing

« Back to Dashboard

Engate Inc v. Esquire Deposition (N.D. Ill. 2001)

Docket ➤ Try a Free Trial Date Filed 2001-08-13
Court District Court, N.D. Illinois Date Terminated 2004-03-26
Cause 28:1338 Patent Infringement Assigned To Matthew F. Kennelly
Jury Demand Both Referred To
Parties ATKINSON-BAKER, INC.; DICKMAN DAVENPORT, INC.; ENGATE, INC.; ESQUIRE DEPOSITION SERVICES; ESQUIRE DEPOSITION SERVICES LLC; FINK & CARNEY COURT REPORTERS AND VIDEO SERVICES; LEGALINK CORP.; SPHERION CORPORATION; THE REPORTERS' GROUP; WORDWAVE INC
Patents 10,183,064
Attorneys Alan R. Lipton; Carolyn C Andrepont; Charles Thomas Riggs , Jr.; David C. Bohan; David P Henry; Gina Marie Steele; Glen P. Belvis; Gregory M. Jordan; James A. Collins; John William Guarisco; Joseph A Grear; Joseph William Flerlage; Kathleen Anne O'Connor; Lee F. Grossman; Reginald Juvann Hill; Richard A. Kaplan; Stephen C. Veltman; Terry David Weissman; Thomas Arthur Miller; Thomas I. Ross; Timothy Todd Patula; William D Sims; William T Enos
Firms Federal Deposit Insurance Corporation; Katten Muchin Rosenman, LLP; Marshall Gerstein & Borun LLP; Miller Canfield; Oblon Spivak, McClelland, Maier & Neustadt, P.C.; Pretzel & Stouffer, Chtd.; Vinson and Elkins
Link to Docket External link to docket
Biologic Drugs cited in Engate Inc v. Esquire Deposition
The biologic drug covered by the patent cited in this case is ➤ Try a Free Trial .

Details for Engate Inc v. Esquire Deposition (N.D. Ill. 2001)

Date Filed Document No. Description Snippet Link To Document
2006-03-13 354 that only eighty percent of these expenses ($10,183.64) were necessary and therefore recoverable. See… Atkinson-Baker, Inc. for the infringement of patents covering technologies related to real-time transcription…concluded that a number of the claims in Engate’s patents were invalid. Pursuant to Rule 54(d) of the Federal… 1 Dennerline and Dowell are patent attorneys who were hired by Engate to examine several…and determine whether they infringed on Engate’s patents. Sanchez is a court reporter who is knowledgeable External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Johnson and Johnson
QuintilesIMS
Moodys
Fuji
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.